Detailed answers about EXCELYA CLINICAL RESEARCH LIMITED, including incorporation, status, business activity, and accounts information.
When was EXCELYA CLINICAL RESEARCH LIMITED founded?
EXCELYA CLINICAL RESEARCH LIMITED was officially incorporated on 8 July 2021 and is registered under company number 13500517. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is EXCELYA CLINICAL RESEARCH LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of EXCELYA CLINICAL RESEARCH LIMITED?
EXCELYA CLINICAL RESEARCH LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does EXCELYA CLINICAL RESEARCH LIMITED do?
EXCELYA CLINICAL RESEARCH LIMITED operates in the following sectors: 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering, 78300 - Human resources provision and management of human resources functions, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is EXCELYA CLINICAL RESEARCH LIMITED's registered address?
The registered office address of EXCELYA CLINICAL RESEARCH LIMITED is 20-22 VENTURE WEST, GREENHAM BUSINESS PARK, NEWBURY, ENGLAND, RG19 6HX. This is the official address filed with Companies House for legal and statutory correspondence.
Is EXCELYA CLINICAL RESEARCH LIMITED financially stable?
The most recent accounts for EXCELYA CLINICAL RESEARCH LIMITED were made up to 31 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.